Every 10-Q that Dolby Laboratories, Inc. (DLB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow DLB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DLB filings page.
Dolby Laboratories reported total revenue of 304,995 (in thousands) for the quarter ended June 26, 2026, slightly below 315,546 (in thousands) a year earlier, as licensing continued to contribute 93% of revenue. International markets supplied 66% of revenue, with broadcast and mobile remaining the largest licensing segments.
Net income attributable to Dolby declined to 28,602 (in thousands) from 46,071 (in thousands), and diluted EPS was $0.30 versus $0.48. Operating income fell to 34,316 (in thousands), reflecting higher restructuring charges and modestly higher operating expenses. The effective tax rate increased to 33.3% from 16.2%, reducing after‑tax earnings.
Year to date, revenue was 1,047,331 (in thousands), slightly above 1,042,106 (in thousands), while net income attributable to Dolby decreased to 176,844 (in thousands) from 205,686 (in thousands). Dolby ended the period with cash and cash equivalents of 669,394 (in thousands) and long‑term investments of 86,437 (in thousands), after funding 200,001 (in thousands) of share repurchases year to date and paying cash dividends of $0.36 per share in each of the first three fiscal quarters.
Dolby Laboratories reported solid results for the fiscal quarter ended March 27, 2026, with modest growth and continued cash returns to shareholders. Total revenue rose to $395.6 million from $369.6 million, led by licensing revenue of $372.2 million, or 94% of sales. Net income attributable to Dolby increased to $94.9 million, with diluted EPS of $0.99 versus $0.94 a year earlier.
Year-to-date, revenue reached $742.3 million, while net income declined to $148.2 million from $159.6 million as operating expenses and restructuring charges remained elevated. Dolby generated $147.3 million of operating cash flow year-to-date, ended the quarter with $594.3 million in cash and cash equivalents, and continued its capital return program with $135.0 million of share repurchases and quarterly dividends of $0.36 per share.
Dolby Laboratories reported net income attributable to the company of $53.3 million for the fiscal quarter ended December 26, 2025, on revenue of $346.7 million, down modestly from $357.0 million a year earlier. Licensing remained the core driver, contributing $319.8 million, or 92% of total revenue.
Net income declined from $67.8 million as operating income fell to $62.2 million, partly reflecting higher restructuring charges of $10.5 million. Dolby generated $54.8 million in operating cash flow and ended the quarter with $643.8 million in cash and cash equivalents plus $83.7 million in restricted cash, after repurchasing $70.0 million of stock and paying $34.3 million in dividends.